HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors

Stephen A. Migueles(National Institutes of Health), M. Shirin Sabbaghian(National Institutes of Health), W. Lesley Shupert(National Institutes of Health), Maria Bettinotti(National Institutes of Health), Francesco M. Marincola(National Institutes of Health), Lisa Martino(National Institutes of Health), Clair W. Hallahan(National Institutes of Health), Sara Selig(National Institutes of Health), David H. Schwartz(National Institutes of Health), John Sullivan(National Institutes of Health), Mark Connors(National Institutes of Health)
Proceedings of the National Academy of Sciences
February 29, 2000
Cited by 993Open Access
Full Text

Abstract

A unique cohort of HIV-1-infected long term nonprogressors (LTNP) with normal CD4(+) T cell counts and <50 copies/ml of plasma were prospectively recruited for study. HLA typing revealed a dramatic association between the HLA B*5701 class I allele and nonprogressive infection [85% (11 of 13) vs. 9.5% (19 of 200) in progressors; P < 0. 001]. Antigen-specific CD8(+) T cells were enumerated by flow cytometric detection of intracellular IFN-gamma in response to HIV antigens and HLA B*57-gag tetramer staining. No quantitative differences in the total HIV-specific CD8(+) T cell responses were observed between B*57(+) LTNP and five B*57(+) progressors (P = 0.4). Although similar frequencies of peptide specific CD8(+) T cells were also found, the gag-specific CD8(+) T cell response in the LTNP group was highly focused on peptides previously shown to be B*57-restricted. These findings indicate that, within this phenotypically and genotypically distinct cohort, a host immune factor is highly associated with restriction of virus replication and nonprogressive disease. They also strongly suggest a mechanism of virus specific immunity that directly operates through the B*5701 molecule. Further characterization of qualitative differences in the virus-specific responses that distinguish HLA B*57(+) LTNP from progressors may ultimately define mechanisms of effective immune mediated restriction of virus replication.


Related Papers

No related papers found

Powered by citation graph analysis